Interesting talk by Jonathan Pettinger from GSK at #CovModDrugDiscov.
He talked about the power of direct-to-biology (D2B) approaches for fast SAR studies of #CovalentInhibitors.
#D2B #DirectToBiology #DrugDiscovery #ChemBio #ChemSky #Science
@stephanhacker2.bsky.social